Skip to Main Content
Home
Team
18
Investments
24
News
280
Home
Team
18
Investments
24
News
280
Back to News
8.29.2023
Clene Reports Significantly Improved Survival Benefit of 19.3 Months and Significantly Delayed Clinical Worsening in RESCUE-ALS Open-Label Extension Two-Year Follow-Up